C-C趋化因子受体6型
CCL17型
20立方厘米
趋化因子受体
中央控制室4
癌症研究
趋化因子受体
CCL22型
趋化因子
化学
生物
免疫学
炎症
作者
Deyu Chen,Ruiwei Jiang,Chaoming Mao,Liang Shi,Shengjun Wang,Long-Chuan Yu,Qin Hu,Dongfang Dai,Huilin Xu
标识
DOI:10.1016/j.humimm.2012.07.333
摘要
Chemokine/chemokine receptor interactions play a critical role in lymphocyte infiltration of tumors. Recent studies suggest that Th17 cells accumulate within many types of tumors, although the mechanisms that control this are unclear. We studied the distribution and phenotypic features of Th17 cells chemokine receptors, as well as the mRNA levels of CCL2, CCL17, CCL20, and CCL22 in tumors of patients with esophageal squamous cell carcinoma. We found that Th17 cells accumulated in tumors, and high expressions of CCR4, CCR6 were detected in Th17 cells. Levels of the chemokines CCL17, CCL20, and CCL22 in tumors were significantly higher than in tumor-free tissues, and were positively correlated with the distribution of Th17 cells in tumors. Furthermore, an in vitro migration assay showed that CCL17, CCL20 and CCL22 had chemotactic effects on tumor-derived Th17 cells. In conclusion, the CCR4-CCL17/22 and CCR6-CCL20 axis might play an important role in Th17 cell infiltration of tumors.
科研通智能强力驱动
Strongly Powered by AbleSci AI